Future concepts in bronchodilation for COPD: dual- versus monotherapy

Most patients with COPD are recommended to initiate maintenance therapy with a single long-acting bronchodilator, such as a long-acting muscarinic antagonist or long-acting β(2)-agonist. However, many patients receiving mono-bronchodilation continue to experience high symptom burden, suggesting that...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Dave, Donohue, James F., Boucot, Isabelle H., Barnes, Neil C., Compton, Chris, Martinez, Fernando J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2021
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489138/
https://www.ncbi.nlm.nih.gov/pubmed/34415847
http://dx.doi.org/10.1183/16000617.0023-2021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489138/
https://www.ncbi.nlm.nih.gov/pubmed/34415847
http://dx.doi.org/10.1183/16000617.0023-2021

Ejemplares similares